Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C

Molecules, Free Full-Text

Nanomaterials, Free Full-Text

Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles: Journal of Biomolecular Structure and Dynamics: Vol 0, No 0

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C

A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C9TB02259G

Enhancing cancer immunotherapy with nanomedicine

Cancer nanomedicine for combination cancer immunotherapy

Nanomedicine-based cancer immunotherapy: recent trends and future perspectives

Doxorubicin-conjugated β-NaYF4:Gd3+/Tb3+ multifunctional, phosphor nanorods: a multi-modal, luminescent, magnetic probe for simultaneous optical and magnetic resonance imaging and an excellent pH-triggered anti-cancer drug delivery nanovehicle

Delivery of cancer therapies by synthetic and bio-inspired nanovectors, Molecular Cancer

Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C

Carrier-free nanodrugs for safe and effective cancer treatment - ScienceDirect